Nicole Robillard's research while affiliated with Centre hospitalier de l'Université de Montréal (CHUM) and other places
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publications (3)
The increase in longevity (and secondary morbidity) in the Quebec population adds social and financial pressure to society, as it does elsewhere in Canada and in many western countries. This article gives a brief history of the evolution of vision rehabilitation services in Quebec and describes how services are provided for people with low vision t...
Case report:
In India and Southeast Asia, rhinosporidiosis is a common infectious disease, but it has rarely been reported in western countries. Infrequently, isolated ocular rhinosporidial infections have been reported, but to our knowledge, there are no reported cases in Canada. Two cases of rhinosporidiosis have been recently diagnosed and mana...
To compare the efficacy and safety of famciclovir with aciclovir for the treatment of ophthalmic zoster.
Randomised, double masked, aciclovir controlled, parallel group in 87 centres worldwide including 454 patients with ophthalmic zoster of trigeminal nerve (V(1)) comprised the intent to treat population. Oral famciclovir 500 mg three times daily...
Citations
... However, one of the main disadvantages of acyclovir is the rare occurrence of drug resistance, particularly in patients who are immunocompromised, as well as causing renal toxicity at high systemic doses [174,175]. There are multiple analogues of acyclovir, such as valacyclovir, famciclovir, and ganciclovir, all possessing a similar mechanism of action, but with differing bioavailability and dosing regimens [176][177][178]. ...
... Rhinosporidiosis has been reported from about 70 countries with [5] diverse geographical features. Infrequently, isolated cases are [6] reported in other parts of the world, mainly due to migration. The route of transmission of Rhinosporidium remains unclear even though the presumed mode of infection from the natural aquatic habitat of Rhinosporidium seeberi is through the traumatized epithelium ('transepithelial infection'), most commonly in nasal sites. ...
... LVAs aim at improving visual ability and consequently enhance the functional status of the affected individuals. The results of our study are in line with previous studies suggesting that one of the most common forms of intervention is the prescription of magnification devices [26,35,38,39]. Specifically, in our study, the majority of patients who received an LVA preferred a handheld, illuminated magnifier to magnify objects and to facilitate near reading of relatively small prints [26,38,39]. ...